Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

RNAZ Transcode Therapeutics

Watchlist
0.565
-0.055-8.87%
Close  02/07 16:00 ET
0.567
+0.001+0.21%
Post Mkt Price 02/07 19:27 ET
High
0.590
Open
0.590
Turnover
158.58K
Low
0.560
Pre Close
0.620
Volume
275.51K
Market Cap
7.34M
P/E(TTM)
Loss
52wk High
3.080
Shares
12.98M
P/E(Static)
Loss
52wk Low
0.281
Float Cap
4.92M
Bid/Ask %
0.00%
Historical High
7.000
Shs Float
8.70M
Volume Ratio
0.07
Historical Low
0.281
Dividend TTM
--
Div Yield TTM
--
P/B
0.89
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.17%
Amplitude
4.84%
Avg Price
0.575
Lot Size
1
Float Cap
4.92M
Bid/Ask %
0.00%
Historical High
7.000
Shs Float
8.70M
Volume Ratio
0.07
Historical Low
0.281
Dividend TTM
--
P/B
0.89
Dividend LFY
--
Turnover Ratio
3.17%
Amplitude
4.84%
Avg Price
0.575
Lot Size
1
Price Forecast

News

Comment

Company Overview More
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
CEO: Mr. Robert Michael Dudley
Market: NASDAQ
Listing Date: 07/09/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist